Combining Dual Checkpoint Immunotherapy with Ablative Radiation to All Sites of Oligometastatic Non-Small Cell Lung Cancer: Toxicity and Efficacy Results of a Phase 1b Trial
M. Bassetti, Brett Morris, Nan Sethakorn, Joshua M. Lang, Jennifer L. Schehr, Shuang G. Zhao, Zachary S. Morris, Darya Buehler, Jens C. Eickhoff, Paul M. Harari, Anne M. Traynor, Toby C. Campbell, Andrew M. Baschnagel, Ticiana Leal
Topics & Concepts
MedicineDurvalumabImmunotherapyOncologyAbscopal effectInternal medicineNivolumabLung cancerTremelimumabRadiation therapyCancerIpilimumabCancer Immunotherapy and BiomarkersLung Cancer Diagnosis and TreatmentImmunotherapy and Immune Responses